Clinical Trial Update: Intravenous Metoclopramide in the Acute Treatment of Migraine: A Double-blind, Randomized, Placebo-controlled Trial [Phase 4]

View source ↗

Summary

Phase 4 double-blind, randomized, placebo-controlled trial evaluating intravenous metoclopramide for acute treatment of migraine has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Metoclopramide (metoclopramide)

Snippet

Sponsor: Kocaeli University | Conditions: Migraine Disorders | Phase 4 | Status: COMPLETED